Is BioAge Labs Inc. overvalued?

BioAge Labs Inc. (BIOA) — key valuation metrics and fundamentals.

No verdict

Price

$10.60

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$399.1M

Dividend yield

0.0%

Return on equity

-29.0%

Sector

Healthcare

Fair value compares BIOA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks